Chimerix, Inc.
(NASDAQ : CMRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.09%195.871.2%$487.90m
GILDGilead Sciences, Inc.
-1.49%71.270.9%$439.64m
BIIBBiogen Inc.
-1.15%311.901.3%$340.73m
ILMNIllumina, Inc.
-3.35%306.623.5%$329.95m
CELGCelgene Corporation
-1.54%79.371.2%$318.83m
VRTXVertex Pharmaceuticals Incorporated
-2.99%172.101.9%$229.20m
REGNRegeneron Pharmaceuticals, Inc.
-1.78%380.882.6%$219.98m
ALXNAlexion Pharmaceuticals, Inc.
-1.81%121.682.0%$214.18m
SRPTSarepta Therapeutics, Inc.
-1.23%130.9316.4%$163.94m
AAgilent Technologies, Inc.
-3.53%62.011.5%$149.45m
BMRNBioMarin Pharmaceutical Inc.
-3.56%99.854.4%$134.42m
LGNDLigand Pharmaceuticals Incorporated
-3.32%178.7523.3%$114.28m
EXASExact Sciences Corporation
-0.96%61.6525.3%$104.56m
ECYTEndocyte, Inc.
0.09%23.542.1%$95.93m
NBIXNeurocrine Biosciences, Inc.
-2.66%106.275.1%$93.15m

Company Profile

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.